Initial Therapy of Panretinal Photocoagulation vs Anti-VEGF Injection for Proliferative Diabetic Retinopathy.

ABSTRACT:

Importance

While combined treatment of anti-vascular endothelial growth factor (VEGF) injections plus panretinal photocoagulation (PRP) is a common approach for treating proliferative diabetic retinopathy (PDR) in the clinical practice setting, large randomized clinical trials typically use monotherapy. Subsequently, information is limited as to whether the order of treatment when combining PRP and anti-VEGF injections for PDR affects outcomes.

Objective

To compare outcomes of patients with PDR treated with PRP and subsequent anti-VEGF injections with outcomes of matched patients treated with anti-VEGF injections and subsequent PRP.

Design, setting, and participants

This retrospective cohort study used data from January 2003 to January 2024 in the TriNetX aggregated e

SUBMITTER: Alsoudi AF 

PROVIDER: S-EPMC11362971 | biostudies-literature | 2024 Oct

REPOSITORIES: biostudies-literature